Indonesia, East Java (2015)
|
Sample size
|
2842 |
|
Response rate
|
99.3% |
|
RAAB version
|
RAAB6 |
|
Diabetic retinopathy
|
No |
|
Disability module
|
No |
Vision impairment
Prevalence (age-sex adjusted)
|
Female
|
Male
|
Total
|
|||||||
|
|
Extrapolated magnitude
|
%
|
95% CI
|
Extrapolated magnitude
|
%
|
95% CI
|
Extrapolated magnitude
|
%
|
95% CI
|
|
Blind
|
177 687
|
4.1
|
3.0 - 5.2
|
193 905
|
4.7
|
2.5 - 6.9
|
371 593
|
4.4
|
3.1 - 5.6
|
|
Severe
|
166 659
|
3.8
|
2.9 - 4.8
|
112 903
|
2.7
|
1.6 - 3.8
|
279 561
|
3.3
|
2.5 - 4.0
|
|
Moderate
|
453 493
|
10.5
|
8.4 - 12.5
|
382 588
|
9.2
|
7.4 - 11.0
|
836 081
|
9.8
|
8.1 - 11.6
|
|
Mild
|
641 685
|
14.8
|
11.1 - 18.5
|
509 715
|
12.2
|
8.6 - 15.9
|
1 151 400
|
13.5
|
10.3 - 16.8
|
Cataract
Operable cataract prevalence (age-sex adjusted)
|
Female
|
Male
|
Total
|
|||||||
|
|
Extrapolated magnitude
|
%
|
95% CI
|
Extrapolated magnitude
|
%
|
95% CI
|
Extrapolated magnitude
|
%
|
95% CI
|
|
<3/60
|
105 906
|
2.4
|
1.7 - 3.2
|
111 147
|
2.7
|
0.7 - 4.6
|
217 053
|
2.6
|
1.6 - 3.5
|
|
<6/60
|
241 040
|
5.6
|
4.3 - 6.9
|
179 014
|
4.3
|
2.0 - 6.6
|
420 054
|
4.9
|
3.6 - 6.3
|
|
<6/18
|
483 249
|
11.1
|
9.1 - 13.2
|
365 356
|
8.8
|
6.0 - 11.5
|
848 605
|
10.0
|
8.0 - 12.0
|
|
<6/12
|
773 636
|
17.8
|
15.0 - 20.7
|
586 906
|
14.1
|
10.5 - 17.7
|
1 360 542
|
16.0
|
13.3 - 18.7
|
Cataract surgical coverage (CSC) (age-sex adjusted)
|
Female
|
Male
|
Total
|
|||||||
|
|
|
%
|
95% CI
|
|
%
|
95% CI
|
|
%
|
95% CI
|
|
CSC<3/60
|
-
|
32.2
|
21.2 - 43.1
|
-
|
29.0
|
9.5 - 9.5
|
-
|
30.6
|
21.0 - 43.4
|
|
CSC<6/60
|
-
|
19.8
|
11.7 - 27.9
|
-
|
21.5
|
8.1 - 35.0
|
-
|
20.6
|
12.2 - 27.5
|
|
CSC<6/18
|
-
|
11.0
|
6.1 - 15.9
|
-
|
14.3
|
6.4 - 22.3
|
-
|
12.4
|
6.1 - 15.8
|
|
CSC<6/12
|
-
|
7.1
|
4.0 - 10.3
|
-
|
9.4
|
4.2 - 14.7
|
-
|
8.1
|
4.0 - 10.3
|
Effective cataract surgical coverage (eCSC) (age-sex adjusted)
The RAAB research team are in the process of concluding a formal analysis of eCSC with the World Health Organization and the Vision Loss Expert Group. eCSC results will be available on the repository in 2022.
Refractive error
Vision impairing refractive error is defined as presenting VA less than 6/12 improving to 6/12 with pinhole. Use of presenting VA accounts for the prevalence of uncorrected or undercorrected refractive error only.
Vision impairing refractive error prevalence (age-sex adjusted)
|
Female
|
Male
|
Total
|
|||||||
|
|
Extrapolated magnitude
|
%
|
95% CI
|
Extrapolated magnitude
|
%
|
95% CI
|
Extrapolated magnitude
|
%
|
95% CI
|
|
Blind
|
2 218
|
0.1
|
0.0 - 0.2
|
0
|
0.0
|
0.0 - 0.0
|
2 218
|
0.0
|
0.0 - 0.1
|
|
Severe
|
1 700
|
0.0
|
0.0 - 0.2
|
3 832
|
0.1
|
0.0 - 0.3
|
5 532
|
0.1
|
0.0 - 0.2
|
|
Moderate
|
62 831
|
1.4
|
0.9 - 2.0
|
46 044
|
1.1
|
0.4 - 1.8
|
108 876
|
1.3
|
0.9 - 1.7
|
|
Mild
|
295 257
|
6.8
|
4.4 - 9.2
|
310 397
|
7.5
|
4.8 - 10.1
|
605 654
|
7.1
|
5.0 - 9.2
|
Effective refractive error coverage (eREC) (age-sex adjusted)
The RAAB research team are in the process of concluding a formal analysis of eREC with the World Health Organization and the Vision Loss Expert Group. eREC results will be available on the repository in 2022.
Notes
Vision impairment categories defined according to WHO thresholds using presenting visual acuity in the better eye.
All prevalence and coverage estimates are adjusted to the age and gender distribution of the population 50 years and older in the survey area.
All 95% confidence intervals adjusted to account for the cluster design of the survey.